In this issue of Hematology/Oncology Clinics, guest editors Drs. Sarah B. Goldberg and Roy S. Herbst bring their considerable expertise to the topic of Lung Cancer. Top experts in the field cover key topics such as state-of-the-art pathologic and molecular testing; neoadjuvant vs. adjuvant therapy for early-stage NSCLC; new therapies on the horizon (immunotherapy, ADCs, etc.); supportive care and symptom management; smoking cessation; and more.
Contains 15 relevant, practice-oriented topics including lung cancer screening; advances in surgical techniques for lung cancer; non-surgical therapy for early-stage lung cancer; locally advanced lung cancer; what’s new in small cell lung cancer; and more.
Provides in-depth clinical reviews on lung cancer, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. x 7. Preface - p. xi 8. State of the Art of Pathologic and Molecular Testing - p. 463 9. Convergence of Precision Oncology and Liquid Biopsy in Non-Small Cell Lung Cancer - p. 475 10. Advances in Surgical Techniques for Lung Cancer - p. 489 11. Nonsurgical Therapy for Early-Stage Lung Cancer - p. 499 12. The Evolving Role for Systemic Therapy in Resectable Non-small Cell Lung Cancer - p. 513 13. Locally Advanced Lung Cancer - p. 533 14. First-Line Treatment of Driver-Negative Non–Small Cell Lung Cancer - p. 557 15. Targeted Therapy for Non–Small Cell Lung Cancer: First Line and Beyond - p. 575 16. What Is New in Small Cell Lung Cancer - p. 595 17. Lung Cancer Supportive Care and Symptom Management - p. 609 18. New Therapies on the Horizon - p. 623
In this issue of Hematology/Oncology Clinics, guest editors Drs. Sarah B. Goldberg and Roy S. Herbst bring their considerable expertise to the topic of Lung Cancer. Top experts in the field cover key topics such as state-of-the-art pathologic and molecular testing; neoadjuvant vs. adjuvant therapy for early-stage NSCLC; new therapies on the horizon (immunotherapy, ADCs, etc.); supportive care and symptom management; smoking cessation; and more.
Contains 15 relevant, practice-oriented topics including lung cancer screening; advances in surgical techniques for lung cancer; non-surgical therapy for early-stage lung cancer; locally advanced lung cancer; what’s new in small cell lung cancer; and more.
Provides in-depth clinical reviews on lung cancer, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. x 7. Preface - p. xi 8. State of the Art of Pathologic and Molecular Testing - p. 463 9. Convergence of Precision Oncology and Liquid Biopsy in Non-Small Cell Lung Cancer - p. 475 10. Advances in Surgical Techniques for Lung Cancer - p. 489 11. Nonsurgical Therapy for Early-Stage Lung Cancer - p. 499 12. The Evolving Role for Systemic Therapy in Resectable Non-small Cell Lung Cancer - p. 513 13. Locally Advanced Lung Cancer - p. 533 14. First-Line Treatment of Driver-Negative Non–Small Cell Lung Cancer - p. 557 15. Targeted Therapy for Non–Small Cell Lung Cancer: First Line and Beyond - p. 575 16. What Is New in Small Cell Lung Cancer - p. 595 17. Lung Cancer Supportive Care and Symptom Management - p. 609 18. New Therapies on the Horizon - p. 623
